home / stock / capr / capr news

CAPR News and Press, Capricor Therapeutics Inc. From 03/24/20

Stock Information
Company Name: Capricor Therapeutics Inc.
Stock Symbol: CAPR
Market: NASDAQ
Website: capricor.com
Menu
CAPR CAPR Quote CAPR Short CAPR News CAPR Articles CAPR Message Board
Get CAPR Alerts

News, Short Squeeze, Breakout and More Instantly...
CAPR - Capricor Therapeutics to Host a Key Opinion Leader Call On Why Exosomes are Uniquely Suited for Vaccine Development

LOS ANGELES, March 24, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and other rare disorders, today announ...
CAPR - Capricor Therapeutics' (CAPR) CEO Linda Marban on Q4 2019 Results - Earnings Call Transcript

Capricor Therapeutics, Inc. (CAPR) Q4 2019 Earnings Conference Call March 18, 2020, 04:30 PM ET Company Participants AJ Bergmann - CFO Linda Marban - President and CEO Conference Call Participants Joseph Pantginis - H.C. Wainwright Jason McCarthy - Maxim Group Presentati...

CAPR - Capricor Therapeutics EPS in-line, beats on revenue

Capricor Therapeutics (NASDAQ: CAPR ): Q4 GAAP EPS of -$0.34 in-line. More news on: Capricor Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CAPR - Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

-To Report Final 12-month HOPE-2 Data in the Second Quarter- -Exosomes Platform Technology Expanded to Potentially Combat the Novel Coronavirus- -To Host Conference Call and Webcast Today at 4:30 p.m. ET- LOS ANGELES, March 18, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics ...
CAPR - SLS, APRN among premarket gainers

Biomerica (NASDAQ: BMRA ) +133%  on advancement of rapid coronavirus test. More news on: Biomerica, Inc., IMV Inc., Vaxart, Inc., Stocks on the move, , Read more ...

CAPR - Capricor Therapeutics Announces Strategic Plan for Exosome Platform Technology Products Expansion

LOS ANGELES, March 17, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and other rare disorders, today announc...

CAPR - Capricor Therapeutics to Present Fourth Quarter and Full Year 2019 Financial Results and Recent Corporate Update on March 18

LOS ANGELES, March 11, 2020 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other rare disorders will release its fin...
CAPR - The Reincarnation Of ThermoGenesis With A Better Mousetrap For CAR-T Manufacturing

Introduction Back in the 1990s, ThermoGenesis Holdings Inc. ( THMO ) was one of the early public company pioneers seeking to bring stem cell and regenerative medicine therapies to the market when it traded under the symbol KOOL. Primarily a cell processing device company, it eventually i...

CAPR - Capricor Therapeutics Announces Closing of $5.1 Million Offering Priced At-the-Market

LOS ANGELES, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc.  (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other rare disorders, today anno...

CAPR - Capricor Therapeutics Announces Pricing of $5.1 Million Offering Priced At-the-Market

LOS ANGELES, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc.  (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy and other rare disorders, today anno...
Previous 10 Next 10